Home » Topics » BioWorld Science

BioWorld Science
RSS

Brain-targeted gene editing using CRISPR-Gold in mice models of fragile X syndrome

July 16, 2018

BGI-Shenzhen synthesizes new cancer vaccines

July 16, 2018

RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome

July 16, 2018

FDA approves Xtandi for nonmetastatic castration-resistant prostate cancer

July 16, 2018

Researchers find a relationship between prediabetes and overactive bladder

July 16, 2018

FDA approves first drug to treat smallpox

July 16, 2018

Atossa Genetics initiates phase II study of endoxifen in neoadjuvant breast cancer

July 16, 2018

GlaxoSmithKline presents NRF2 activators

July 16, 2018

University of Nebraska identifies NF-kappaB activation inhibitors

July 16, 2018

OBI Pharma initiates phase I study of OBI-888 in patients with solid tumors

July 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...